首頁 › 間質性肺病 › 堪薩斯 › Kansas City
Kansas City, KS 的 間質性肺病 臨床試驗
13 項針對 間質性肺病 的研究正在 Kansas City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中觀察性研究
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
招募中觀察性研究
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
招募中1 期歡迎健康志工
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
招募中觀察性研究
- University of Kansas, Kansas City
其他城市的 間質性肺病 試驗
- New York City, NY18 項研究
- Philadelphia, PA16 項研究
- Los Angeles, CA14 項研究
- Charleston, SC13 項研究
- Durham, NC13 項研究
- Chicago, IL12 項研究
- Houston, TX12 項研究
- Aurora, CO11 項研究
- Ann Arbor, MI11 項研究
- Dallas, TX9 項研究
- Salt Lake City, UT9 項研究
- Boston, MA9 項研究
Kansas City 的其他研究
- 心血管疾病14 項研究
- 心臟衰竭13 項研究
- 肥胖症13 項研究
- 囊腫性纖維化13 項研究
- 乳癌12 項研究
- 膀胱癌12 項研究
- 急性髓系白血病12 項研究
- 前列腺癌12 項研究
- 非小細胞肺癌11 項研究
- 肺癌11 項研究
- 慢性阻塞性肺病9 項研究
- 氣喘8 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。